Sema4 Holdings Corp - Ordinary Shares - Class A Stock News

With the way negative stock market sentiment  has piled up recently, short squeezes have generated some massive returns.

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced that company management will participate in upcoming investor conferences.

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx announced the publication of a new article demonstrating the company's leadership in applying AI to accelerate and enhance genetic diagnostics.

GeneDx delivered strong Q1 2025 results, beating revenue and EPS estimates, and raised full-year guidance despite a minor sequential test volume dip. The volume decline is attributable to seasonality, adverse weather, and one fewer business day, not a structural slowdown; fundamentals remain robust. Strong pricing power and rising reimbursement rates drive revenue growth, setting a solid founda...

The top five biotech stocks today have several commonalities. Among them are strong ratings.

GeneDx's recent 50% stock drop post-Q1 earnings is seen as an overreaction, despite a projected modest growth slowdown from 42% to 30-35%. The company is expanding product lines, improving margins, and increasing insurance coverage, with the recent acquisition of Fabric Genomics offering growth and cost synergies. GeneDx's valuation is attractive compared to peers, with a forward P/E of 30 and ...

GAITHERSBURG, Md. & OAKLAND, Calif.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced the successful completion of its acquisition of Fabric Genomics, a pioneer in AI-powered genomic interpretation.

With a nearly 39% stock price decline this week, according to data compiled by S&P Global Market Intelligence, GeneDx Holdings (WGS 7.80%) was deep in the doghouse with investors. They traded out of the stock following the company's latest earnings release and a subsequent round of analyst price target cuts.